Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningeal Carcinomatosis × tucatinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 6 Breast Neoplasms 4 Neoplasms by Site 1 Neoplasms 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Central Nervous System Diseases 1 Breast Diseases 1

Interventions

Pemetrexed 20 Bevacizumab 9 Radiotherapy 8 osimertinib 6 Spinal Puncture 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 aflutinib 4 Trastuzumab 4 Topotecan 4 Temozolomide 4 Radiotherapy, Intensity-Modulated 4 Methotrexate 4 Dexamethasone 3 trastuzumab deruxtecan 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 merphos 2 lorlatinib 2 aumolertinib 2 WP 744 2 Vitamin B 12 2 Rituximab 2 Radiation 2 Folic Acid 2 Drug Therapy 2 Cytarabine 2 Cyclophosphamide 2 Capecitabine 2 Busulfan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05800275 2025-11-18

ETIC-LM

UNICANCER

Phase 2 Recruiting

Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡